- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06432543
Polyethylene Wear Particle Analysis of THA
Polyethylene Wear Particle Analysis of Total Hip Arthroplasty -International Multicenter Study-
Study Overview
Status
Intervention / Treatment
Detailed Description
Research method In this study, the investigators conducted the following steps to determine the in vivo wear particles (number, size, and morphology) of conventional polyethylene, whose long-term results have already been clarified, and vitamin E-containing polyethylene, whose mid- to long-term results have not yet been clarified. Clarifying the difference.
Target of this research In this study, the investigators will focus on patients undergoing revision hip arthroplasty as a routine medical treatment.
First total joint replacement
- 30 patients using polyethylene containing Vitamin E
- 30 patients using conventional polyethylene (no high cross-linking)
- 30 patients using conventional polyethylene (with high cross-linking)
Accumulation of periarticular tissue In this study, the investigators will focus on patients undergoing revision hip arthroplasty as a routine medical treatment.
The test will be conducted after obtaining approval from the ethics committee at each facility and obtaining informed consent. The pericapsular tissue, which is removed during surgery and usually discarded, is obtained and fixed in formalin fixative. The tissue will be transported to the Department of Orthopedic Surgery, Osaka Public University Graduate School of Medicine for analysis. International transportation of tissues requires outsourcing to specialized companies with experience in transporting tissues from overseas.
Isolation of polyethylene wear debris The collected tissue around the joint capsule is immersed in 5Mol sodium hydroxide at 65°C for 1 hour to decompose the protein. Make a sucrose layer (5, 10, 20%) in a 14ml tube (14PA tube, Hitachi Koki Co, Ltd, Tokyo, Japan), add the dissolved solution, and place in an ultracentrifuge (CP100a, P28S1014 rotor, Hitachi Koki). Ultracentrifuge at 28,000 rpm [103,7009g] for 3 hours at 4°C. Prepare an isopropanol layer (0.90 and 0.96 g/mL) in a 40 ml tube (40PA tube, Hitachi Koki Co, Ltd, Tokyo, Japan), add the upper layer of sucrose layer, and centrifuge at 28,000 rpm (103,7009 g) and perform ultracentrifugation at 4°C for 1 hour. The isopropanol interlayer is collected to isolate polyethylene wear debris.
Analysis of polyethylene wear debris The isopropanol interlayer is filtered through a 0.1 μm polycarbonate filter (VCTP 013-00, Millipore Corporation, Bedford, MA). Dry the polycarbonate filter, fix it on an aluminum pedestal (M4, Nisshin EM Co, Ltd, Tokyo, Japan), and apply platinum coating (E-1030 ion sputter, Hitachi Science Systems Ltd, Tokyo, Japan). Observe the polyethylene wear particles on the polycarbonate filter using a scanning electron microscope (S4700SI, Hitachi Ltd, Tokyo, Japan), and analyze the following items using an image analyzer (Mac Scope, Mitani Co, Tokyo, Japan).
- Number of polyethylene wear particles (number per 1g of tissue)
- Size (Equivalent circle diameter [μm])
- Shape (aspect ratio, roundness)
Comparison of iv vivo polyethylene wear powder morphology depending on polyethylene material The number, size, and form of polyethylene wear debris will be compared between conventional polyethylene, whose long-term results have already been clarified, and vitamin E-containing polyethylene, whose medium- to long-term results have not yet been clarified. The investigators also investigated factors that affect polyethylene wear in vivo (age, height, weight, period from initial surgery to revision surgery, hip joint range of motion, hip prosthesis clinical score [Hip dysfunction and Osteoarthritis Outcome Score for Joint Replacement [HOOS Jr], Harris Hip Score, University of California Los Angeles [UCLA] activity score]).
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Kiyoko Kato, MD
- Phone Number: 81-6-6645-3851
- Email: Kiyoko-Kato@omu.ac.jp
Study Locations
-
-
-
Osaka, Japan, 5458585
- Recruiting
- Osaka Metropolitan University
-
Contact:
- Kiyoko Kato, MD
-
Principal Investigator:
- Yukihide Minoda
-
-
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Not yet recruiting
- Mayo Clinic
-
Contact:
- Holly A Roher
- Phone Number: 507-266-0835
- Email: roher.holly@mayo.edu
-
Principal Investigator:
- Nicholas A Bedard, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients undergoing revision hip arthroplasty within the study period
- Patients over 20 years old
- Patients who have received a sufficient explanation, have sufficient understanding, and have given their free written consent.
- Patients who have passed 2 years or more since their first total hip arthroplasty
Exclusion Criteria:
1. Patients who are judged to be unsuitable as research subjects by the research physician
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
polyethylene containing Vitamin E
|
No intervention as this is an observational study
|
|
conventional polyethylene (no highly cross-linking)
|
No intervention as this is an observational study
|
|
conventional polyethylene (with highly cross-linking)
|
No intervention as this is an observational study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of polyethylene wear particles
Time Frame: When tissue sample was collected during THA revision surgery
|
counts / g (tissue sample)
|
When tissue sample was collected during THA revision surgery
|
|
Equivalent circle diameter of polyethylene wear particles
Time Frame: When tissue sample was collected during THA revision surgery
|
equivalent circle diameter [㎛]
|
When tissue sample was collected during THA revision surgery
|
|
Aspect ratio of polyethylene wear particles
Time Frame: When tissue sample was collected during THA revision surgery
|
aspect ratio
|
When tissue sample was collected during THA revision surgery
|
|
Roundness of polyethylene wear particles
Time Frame: When tissue sample was collected during THA revision surgery
|
roundness
|
When tissue sample was collected during THA revision surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body mass index
Time Frame: When tissue sample was collected during THA revision surgery
|
kg/m2
|
When tissue sample was collected during THA revision surgery
|
|
Hip joint flexion angle
Time Frame: When tissue sample was collected during THA revision surgery
|
Degrees
|
When tissue sample was collected during THA revision surgery
|
|
Hip joint exertion angle
Time Frame: When tissue sample was collected during THA revision surgery
|
Degrees
|
When tissue sample was collected during THA revision surgery
|
|
Hip joint adduction angle
Time Frame: When tissue sample was collected during THA revision surgery
|
Degrees
|
When tissue sample was collected during THA revision surgery
|
|
Hip joint abduction angle
Time Frame: When tissue sample was collected during THA revision surgery
|
Degrees
|
When tissue sample was collected during THA revision surgery
|
|
Hip dysfunction and Osteoarthritis Outcome. Score for Joint Replacement
Time Frame: When tissue sample was collected during THA revision surgery
|
0(worse)-100(best)
|
When tissue sample was collected during THA revision surgery
|
|
Harris Hip Score
Time Frame: When tissue sample was collected during THA revision surgery
|
0(worse)-100(best)
|
When tissue sample was collected during THA revision surgery
|
|
University of California at Los Angeles activity score
Time Frame: When tissue sample was collected during THA revision surgery
|
1(worse)-10(best)
|
When tissue sample was collected during THA revision surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yukihide Minoda, MD, PhD, Osaka Metropolitan University
Publications and helpful links
General Publications
- Iwakiri K, Iwaki H, Kobayashi A, Minoda Y, Kagiyama H, Kadoya Y, Takaoka K. Characteristics of Hylamer polyethylene particles isolated from peri-prosthetic tissues of failed cemented total hip arthroplasties. J Biomed Mater Res B Appl Biomater. 2008 Apr;85(1):125-9. doi: 10.1002/jbm.b.30924.
- Hata K, Minoda Y, Ikebuchi M, Mizokawa S, Ohta Y, Miyazaki N, Miyake Y, Nakamura H. In vivo wear particles of remelted highly crosslinked polyethylene after total hip arthroplasty: report of four cases. J Mater Sci Mater Med. 2015 Mar;26(3):133. doi: 10.1007/s10856-015-5472-9. Epub 2015 Feb 25.
- Minoda Y, Kobayashi A, Sakawa A, Aihara M, Tada K, Sugama R, Iwakiri K, Ohashi H, Takaoka K. Wear particle analysis of highly crosslinked polyethylene isolated from a failed total hip arthroplasty. J Biomed Mater Res B Appl Biomater. 2008 Aug;86(2):501-5. doi: 10.1002/jbm.b.31048.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OMU 2023-132
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Arthropathy
-
Centre Hospitalier de MontaubanCompleted
-
Ospedale Edoardo BassiniCompletedRegional Anesthesia Morbidity | Arthropathy of Hip | Hip ArthropathyItaly
-
Xiangya Hospital of Central South UniversityActive, not recruitingKnee Arthropathy | Hip Arthropathy | Ankle Arthropathy | Elbow Arthropathy | Shoulder ArthropathyChina
-
Taipei Veterans General Hospital, TaiwanNot yet recruitingHip Replacement | Hip Arthropathy
-
Masarykova Nemocnice v Usti nad Labem, Krajska...CompletedArthropathy of HipCzechia
-
Universidad de ZaragozaCompletedArthropathy of Knee | Arthropathy of HipSpain
-
Centre Hospitalier Universitaire de la RéunionCompletedArthropathy of Knee | Arthropathy of HipRéunion
-
Wuhan Union Hospital, ChinaRecruiting
-
Societe dEtude, de Recherche et de FabricationCompleted
-
Yale UniversityCompletedHip ArthropathyUnited States
Clinical Trials on polyethylene
-
Zimmer BiometCompleted
-
Mayo ClinicStryker OrthopaedicsCompletedArthroplasty, Replacement, Knee | Total Knee ReplacementUnited States
-
University of PadovaCompletedHypothermia, Preterm Infants
-
Changhai HospitalUnknownAdenoma Detection Rate | Bowel Preparation ScaleChina
-
Valdoltra Orthopedic HospitalActive, not recruitingEvaluation of Polyethylene Wear After Failed TKASlovenia
-
Cook County HealthCompletedBowel Preparation for ColonoscopyUnited States
-
Cleveland Clinic FloridaCompletedColon CancerUnited States
-
Oregon Health and Science UniversityUnknownColonoscopyUnited States
-
Selcuk UniversityCompleted
-
Navamindradhiraj UniversityUnknownConstrained Insert in Knee ArthroplastyThailand